Leukemia & Lymphoma, Volume 65, Issue 5 (2024)

Browse this journal

Leukemia & Lymphoma, Volume 65, Issue 5 (2024)

See all volumes and issues
Volume 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Comments

Comment
Pairing obinutuzumab with venetoclax in relapsed CLL
Kerry A. Rogers & Philip A. Thompson
Pages: 543-545
Published online: 18 Mar 2024
First Page PreviewforPairing obinutuzumab with venetoclax in relapsed CLL | Full Text | References | PDF (233.3 KB) | EPUB
  • 56 Views
  • 0 CrossRef citations
  • 0Altmetric
Comment
Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement
Adrian Minson & Michael Dickinson
Pages: 546-547
Published online: 29 Feb 2024
CitationforCombining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement | Full Text | References | PDF (203.9 KB) | EPUB
  • 93 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Articles

Review Article
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations
Naveen Pemmaraju, Yazan F. Madanat, David Rizzieri, Salman Fazal, Raajit Rampal, Gabriel Mannis, Eunice S. Wang, James Foran & Andrew A. Lane
Pages: 548-559
Published online: 23 Feb 2024
AbstractforTreatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1081 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Curative intent therapy for DLBCL in the elderly
Alessandra Tucci, Lorenzo Masina & Stefano Luminari
Pages: 560-569
Published online: 11 Jan 2024
AbstractforCurative intent therapy for DLBCL in the elderly | Full Text | References | PDF (597.5 KB) | EPUB
  • 198 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Hematopoietic cell transplantation (HCT) in MDS patients of older age
Christian Niederwieser & Nicolaus Kröger
Pages: 570-584
Published online: 05 Feb 2024
AbstractforHematopoietic cell transplantation (HCT) in MDS patients of older age | Full Text | References | PDF (900.7 KB) | EPUB
  • 122 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Articles

Article
The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro
Narjis Fatima, Yandong Shen, Kyle Crassini, Olivia Burling, Lauren Thurgood, Edwin J. Iwanowicz, Henk Lang, Donald S. Karanewsky, Richard I. Christopherson, Stephen P. Mulligan & O. Giles Best
Pages: 585-597
Published online: 16 Jan 2024
AbstractforThe CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro | Full Text | References | PDF (3.2 MB) | EPUB | Supplemental
  • 354 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Disparity in treatment patterns among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia: an analysis of patient and contextual factors
Jean A. Yared, Tsung-Ying Lee, Catherine E. Cooke, Abree Johnson, Amanda Summers, Keri Yang, Sizhu Liu, Boxiong Tang & Eberechukwu Onukwugha
Pages: 598-608
Published online: 07 Feb 2024
AbstractforDisparity in treatment patterns among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia: an analysis of patient and contextual factors | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
Versha Banerji, Andrew Aw, Nicole Laferriere, Nizar Abdel-Samad, Anthea Peters, Nathalie A. Johnson, Marie-Pierre Bernard, Sathish Gopalakrishnan, Sarah-Jane Bull, Pierre-André Fournier, Adi J. Klil-Drori, Annette E. Hay, Sue Robinson & Carolyn Owen
Pages: 609-617
Published online: 18 Jan 2024
AbstractforManagement and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 819 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL
Ehsan Tabari, Alexander F. Lovejoy, Hai Lin, Christopher R. Bolen, Seng Lor Saelee, Joshua P. Lefkowitz, David M. Kurtz, Alessia Bottos, Tina G. Nielsen, Joana M. Parreira & Khai T. Luong
Pages: 618-628
Published online: 09 Feb 2024
AbstractforNGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL | Full Text | References | PDF (3.6 MB) | EPUB | Supplemental
  • 182 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study
Sumedha Arya, Lee Mozessohn, Inna Gong, Neil Faught, Ning Liu, Simron Singh, Kelvin Chan & Matthew C. Cheung
Pages: 629-637
Published online: 24 Jan 2024
AbstractforThe impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study | Full Text | References | PDF (1.6 MB) | EPUB
  • 68 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration
Cynthia M. Magro, Taylor Kalomeris, Christina R. Shreve, Julia T. Geyer & Sanjay S. Patel
Pages: 638-646
Published online: 05 Feb 2024
AbstractforSubcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration | Full Text | References | PDF (7.2 MB) | EPUB
  • 48 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma
Yuqin Song, Jianyong Li, Keshu Zhou, Xiaoyan Ke, Zhen Cai, Huilai Zhang, Tingting Yao, Zhen Xia, Yiqiu Wang, Peiqiong Lai, Xiaofeng Liu & Jun Zhu
Pages: 647-652
Published online: 01 Apr 2024
AbstractforPhase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (927 KB) | EPUB | Supplemental
  • 418 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
Matthew M. Lei, Mark N. Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Ford, Ronald A. Nemec, Jeremy S. Abramson & Jacob D. Soumerai
Pages: 653-659
Published online: 31 Jan 2024
AbstractforReal-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma | Full Text | References | PDF (1 MB) | EPUB
  • 277 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma
Isha Mol, Yannan Hu, Thomas W. LeBlanc, Joseph C. Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart & Patrick Hlavacek
Pages: 660-668
Published online: 12 Feb 2024
AbstractforA matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma | Full Text | References | PDF (2.5 MB) | EPUB
  • 2733 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor

Letter to the Editor
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
Anath C. Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P. Iyer, Loretta J. Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S. Neelapu, Michael L. Wang & Preetesh Jain
Pages: 669-673
Published online: 22 Jan 2024
First Page PreviewforEfficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement | Full Text | References | PDF (1.5 MB) | EPUB
  • 320 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter to the Editor
Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment
Curtis Gravenmier, Bijal Shah, Mohammad Hussaini & Ling Zhang
Pages: 674-678
Published online: 19 Jan 2024
First Page PreviewforChimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment | Full Text | References | PDF (9.6 MB) | EPUB
  • 70 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature
Tara Houlihan, Dónal G. Fortune, Clodagh Keohane & Helen L. Richards
Pages: 679-683
Published online: 07 Feb 2024
First Page PreviewforThe psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature | Full Text | References | PDF (920.6 KB) | EPUB
  • 52 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Therapy with mosunetuzumab, a bispecific antibody for relapsed/refractory hairy cell leukemia
Tamar Tadmor & Ilana Levy Yurkovski
Pages: 684-687
Published online: 22 Jan 2024
First Page PreviewforTherapy with mosunetuzumab, a bispecific antibody for relapsed/refractory hairy cell leukemia | Full Text | References | PDF (2 MB) | EPUB
  • 86 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia
Ivan Krecak, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin & Marko Lucijanic
Pages: 688-691
Published online: 22 Jan 2024
First Page PreviewforGlycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia | Full Text | References | PDF (994.6 KB) | EPUB | Supplemental
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL)
Amen Allah Nasr, Xavier Fund, Sylvain Barreau, Christophe Desterke, Claire Borie, Noufissa Oudrhiri, Jamila Faivre, A. Bennaceur-Griscelli & A. G. Turhan
Pages: 692-695
Published online: 31 Jan 2024
First Page PreviewforBIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL) | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Effects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive cells
Seiichi Okabe, Mitsuru Moriyama & Akihiko Gotoh
Pages: 696-699
Published online: 01 Feb 2024
First Page PreviewforEffects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive cells | Full Text | References | PDF (707.6 KB) | EPUB | Supplemental
  • 47 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter to the Editor
Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available
Sylvain Garciaz, Guillaume Berton, Marie-Anne Hospital, Arnaud Guille, José Adélaïde, Colombe Saillard, Yosr Hicheri, Marie-Joëlle Mozziconacci, Estelle Duprez, Christian Récher, Anne-Sophie Alary, Daniel Birnbaum & Norbert Vey
Pages: 700-703
Published online: 08 Feb 2024
First Page PreviewforLong-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available | Full Text | References | PDF (583.2 KB) | EPUB
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric

Corrections

Correction
Correction
Page: (i)
Published online: 09 Mar 2024
CitationforCorrection | Full Text | PDF (87.6 KB) | EPUB
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Correction
Correction
Page: (ii)
Published online: 12 Apr 2024
CitationforCorrection | Full Text | PDF (127.9 KB) | EPUB
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles